Literature DB >> 17823778

Thrombophilic risk factors among 16 Lebanese patients with cerebral venous and sinus thrombosis.

Zaher K Otrock1, Ali T Taher, Wael A Shamseddeen, Rami A Mahfouz.   

Abstract

Cerebral venous and sinus thrombosis (CVST) is a multifaceted disorder. The frequency of inherited and acquired thrombophilia among 16 CVST patients was evaluated. The mean age of the patients was 22.9 years. Five out of the 16 CVST patients (31.2%) showed the G1691A mutation of factor V. The frequency of the C677T methylenetetrahydrofolate reductase (MTHFR) genotype was 50% (8/16) in patients (2 of them were homozygous). Four of the patients (25%) had both factor V Leiden and MTHFR mutation. Three of the patients had positive antiphospholipid antibodies. At the time of CVST, 2 female patients were taking oral contraceptive pills. Four patients were known to have malignancies. Despite the limitation of the sample size, we identified an inherited coagulopathy at high rate in our patients. Combined inherited thrombophilia was also present in 25% of patients. This finding supports the impression of a multifactorial process leading to CVST in Lebanese patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823778     DOI: 10.1007/s11239-007-0093-x

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  5 in total

Review 1.  Thrombosis of the cerebral veins and sinuses.

Authors:  Jan Stam
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

2.  Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group.

Authors:  S F de Bruijn; J Stam; M M Koopman; J P Vandenbroucke
Journal:  BMJ       Date:  1998-02-21

3.  Cerebral venous thrombosis--a review of 38 cases.

Authors:  M G Bousser; J Chiras; J Bories; P Castaigne
Journal:  Stroke       Date:  1985 Mar-Apr       Impact factor: 7.914

4.  Lupus anticoagulant, factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis.

Authors:  Imad Uthman; Ismail Khalil; Raja Sawaya; Ali Taher
Journal:  Clin Rheumatol       Date:  2004-04-14       Impact factor: 2.980

Review 5.  Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism.

Authors:  B Dahlbäck
Journal:  J Intern Med       Date:  1995-03       Impact factor: 8.989

  5 in total
  5 in total

1.  Evaluation of cerebral venous thrombosis secondary to oral contraceptive use in adolescents.

Authors:  Hasan H Özdemir; Sefer Varol; Eşref Akıl; Abdullah Acar; Caner F Demir
Journal:  Neurol Sci       Date:  2014-08-05       Impact factor: 3.307

2.  Cerebral venous thrombosis in the mediterranean area in children.

Authors:  S Menascu; A Lotan; B Ben Zeev; U Nowak-Gottl; G Kenet
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-07-08       Impact factor: 2.576

3.  Cerebral Venous Thrombosis in the Mediterranean Area in Adults. Role of Behçet's Disease as an Underlying Cause.

Authors:  N Y Barlas; G Akman-Demir; S Z Bahar
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-10-24       Impact factor: 2.576

4.  Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis.

Authors:  Mohammad Saadatnia; Neda Naghavi; Farzad Fatehi; Mohammad Zare; Marzieh Tajmirriahi
Journal:  J Res Med Sci       Date:  2012-04       Impact factor: 1.852

5.  Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study.

Authors:  Mohammad Saadatnia; Mansour Salehi; Ahmad Movahedian; Seyed Ziaeddin Samsam Shariat; Mehri Salari; Marzieh Tajmirriahi; Elham Asadimobarakeh; Rasoul Salehi; Gilda Amini; Homa Ebrahimi; Ehsan Kheradmand
Journal:  J Res Med Sci       Date:  2015-06       Impact factor: 1.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.